The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells

Cancer Cell International

Volumn 9, Issue , 2009, Pages

  Nonaka, Mizuho ^a,b   Hashimoto, Yoshie ^a   Takeshima, Shin Nosuke ^a   Aida, Yoko ^a  

^a RIKEN   (Japan)

^b Japanese Foundation of AIDS Prevention   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; PROTEIN C81; UNCLASSIFIED DRUG; VPR PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONSTRUCT; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL;

EID: 69849099204     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-9-20     Document Type: Article

References (48)

1. Aida Y Matsuda G Role of Vpr in HIV-1 nuclear import: Therapeutic implications Curr HIV Res 2009, 7(2):136-143. 10.2174/157016209787581418 19275582
2. Heinzinger NK Bukinsky MI Haggerty SA Ragland AM Kewalramani V Lee MA Gendelman HE Ratner L Stevenson M Emerman M The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells Proc Natl Acad Sci USA 1994, 91(15):7311-7315. 10.1073/pnas.91.15.7311 44389 8041786
3. Kamata M Nitahara-Kasahara Y Miyamoto Y Yoneda Y Aida Y Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr J Virol 2005, 79(6):3557-3564. 10.1128/ JVI.79.6.3557-3564.2005 1075686 15731250
4. Nitahara-Kasahara Y Kamata M Yamamoto T Zhang X Miyamoto Y Muneta K Iijima S Yoneda Y Tsunetsugu-Yokota Y Aida Y Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages J Virol 2007, 81(10):5284-5293. 10.1128/JVI.01928-06 1900242 17344301
5. Kino T Gragerov A Slobodskaya O Tsopanomichalou M Chrousos GP Pavlakis GN Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators J Virol 2002, 76(19):9724-9734. 10.1128/JVI.76.19.9724-9734.2002 136530 12208951
6. Hashizume C Kuramitsu M Zhang X Kurosawa T Kamata M Aida Y Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition Microbes Infect 2007, 9(4):490-497. 10.1016/j.micinf.2007.01.013 17347016
7. Kuramitsu M Hashizume C Yamamoto N Azuma A Kamata M Tanaka Y Aida Y A novel role for Vpr of human immunodeficiency virus type 1 as a regulator of the splicing of cellular pre-mRNA Microbes Infect 2005, 7(910):1150-1160. 10.1016/j.micinf.2005.03.022 15908254
8. Zhang X Aida Y HIV-1 Vpr: A novel role in regulating RNA splicing Curr HIV Res 2009, 7(2):163-168. 10.2174/157016209787581517 19275585
9. Andersen JL Planelles V The role of Vpr in HIV-1 pathogenesis Curr HIV Res 2005, 3(1):43-51. 10.2174/1570162052772988 15638722
10. Le Rouzic E Benichou S The Vpr protein from HIV-1: Distinct roles along the viral life cycle Retrovirology 2005, 2:11. 10.1186/1742-4690-2-11 554975 15725353
11. Felzien LK Woffendin C Hottiger MO Subbramanian RA Cohen EA Nabel GJ HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator Proc Natl Acad Sci USA 1998, 95(9):5281-5286. 10.1073/pnas.95.9.5281 20252 9560267
12. Goh WC Rogel ME Kinsey CM Michael SF Fultz PN Nowak MA Hahn BH Emerman M HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo Nat Med 1998, 4(1):65-71. 10.1038/nm0198-065 9427608
13. Planelles V Jowett JB Li QX Xie Y Hahn B Chen IS Vpr-induced cell cycle arrest is conserved among primate lentiviruses J Virol 1996, 70(4):2516-2524. 190097 8642681
14. Stivahtis GL Soares MA Vodicka MA Hahn BH Emerman M Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology J Virol 1997, 71(6):4331-4338. 191649 9151821
15. Zimmerman ES Chen J Andersen JL Ardon O Dehart JL Blackett J Choudhary SK Camerini D Nghiem P Planelles V Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation Mol Cell Biol 2004, 24(21):9286-9294. 10.1128/MCB.24.21.9286-9294.2004 522272 15485898
16. Zimmerman ES Sherman MP Blackett JL Neidleman JA Kreis C Mundt P Williams SA Warmerdam M Kahn J Hecht FM Grant RM de Noronha CM Weyrich AS Greene WC Planelles V Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo J Virol 2006, 80(21):10407-10418. 10.1128/JVI.01212-06 1641771 16956949
17. McGowan CH Russell P The DNA damage response: Sensing and signaling Curr Opin Cell Biol 2004, 16(6):629-633. 10.1016/j.ceb.2004.09.005 15530773
18. Le Rouzic E Belaidouni N Estrabaud E Morel M Rain JC Transy C Margottin-Goguet F HIV1 Vpr arrests the cell cycle by recruiting DCAF1/ VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase Cell Cycle 2007, 6(2):182-188. 17314515
19. Angers S Li T Yi X MacCoss MJ Moon RT Zheng N Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery Nature 2006, 443(7111):590-593. 16964240
20. He YJ McCall CM Hu J Zeng Y Xiong Y DDB1 functions as a linker to recruit receptor WD40 proteins to CUL4-ROC1 ubiquitin ligases Genes Dev 2006, 20(21):2949-2954. 10.1101/gad.1483206 1620025 17079684
21. Higa LA Wu M Ye T Kobayashi R Sun H Zhang H CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation Nat Cell Biol 2006, 8(11):1277-1283. 10.1038/ncb1490 17041588
22. Jin J Arias EE Chen J Harper JW Walter JC A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1 Mol Cell 2006, 23(5):709-721. 10.1016/j.molcel.2006.08.010 16949367
23. Belzile JP Duisit G Rougeau N Mercier J Finzi A Cohen EA HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase PLoS Pathog 2007, 3(7):e85. 10.1371/journal.ppat.0030085 1914068,1914068 17630831
24. DeHart JL Zimmerman ES Ardon O Monteiro-Filho CM Arganaraz ER Planelles V HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system Virol J 2007, 4:57. 10.1186/1743-422X-4-57 1904188 17559673
25. Hrecka K Gierszewska M Srivastava S Kozaczkiewicz L Swanson SK Florens L Washburn MP Skowronski J Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle Proc Natl Acad Sci USA 2007, 104(28):11778-11783. 10.1073/pnas.0702102104 1906728,1906728 17609381
26. Schrofelbauer B Hakata Y Landau NR HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1 Proc Natl Acad Sci USA 2007, 104(10):4130-4135. 10.1073/pnas.0610167104 1820720 17360488
27. Wen X Duus KM Friedrich TD de Noronha CM The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor J Biol Chem 2007, 282(37):27046-27057. 10.1074/jbc.M703955200 17620334
28. Dehart JL Planelles V Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation J Virol 2008, 82(3):1066-1072. 10.1128/JVI.01628-07 2224437 17855541
29. Muthumani K Zhang D Hwang DS Kudchodkar S Dayes NS Desai BM Malik AS Yang JS Chattergoon MA Maguire HC Jr Weiner DB Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines Oncogene 2002, 21(30):4613-4625. 10.1038/sj.onc.1205549 12096338
30. Stewart SA Poon B Jowett JB Xie Y Chen IS Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells Proc Natl Acad Sci USA 1999, 96(21):12039-12043. 10.1073/pnas.96.21.12039 18408 10518572
31. Siddiqui K Del Valle L Morellet N Cui J Ghafouri M Mukerjee R Urbanska K Fan S Pattillo CB Deshmane SL Kiani MF Ansari R Khalili K Roques BP Reiss K Bouaziz S Amini S Srinivasan A Sawaya BE Molecular mimicry in inducing DNA damage between HIV-1 Vpr and the anticancer agent, cisplatin Oncogene 2008, 27(1):32-43. 10.1038/sj.onc.1210632 17653096
32. McCray AN Ugen KE Heller R Enhancement of anti-melanoma activity of a plasmid expressing HIV-1 Vpr delivered through in vivo electroporation Cancer Biol Ther 2007, 6(8):1269-1275. 17700061
33. McCray AN Ugen KE Muthumani K Kim JJ Weiner DB Heller R Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation Mol Ther 2006, 14(5):647-655. 10.1016/j.ymthe.2006.06.010 16950655
34. Azuma A Matsuo A Suzuki T Kurosawa T Zhang X Aida Y Human immunodeficiency virus type 1 Vpr induces cell cycle arrest at the G(1) phase and apoptosis via disruption of mitochondrial function in rodent cells Microbes Infect 2006, 8(3):670-679. 10.1016/j.micinf.2005.09.002 16480911
35. Nishizawa M Kamata M Katsumata R Aida Y A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest J Virol 2000, 74(13):6058-6067. 10.1128/JVI.74.13.6058-6067.2000 112104 10846089
36. Morellet N Bouaziz S Petitjean P Roques BP NMR structure of the HIV-1 regulatory protein VPR J Mol Biol 2003, 327(1):215-227. 10.1016/ S0022-2836(03)00060-3 12614620
37. Le Rouzic E Morel M Ayinde D Belaidouni N Letienne J Transy C Margottin-Goguet F Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation J Biol Chem 2008, 283(31):21686-21692. 10.1074/jbc.M710298200 18524771
38. Zhao LJ Mukherjee S Narayan O Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein J Biol Chem 1994, 269(22):15577-15582. 8195203
39. Nishizawa M Kamata M Mojin T Nakai Y Aida Y Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle Virology 2000, 276(1):16-26. 10.1006/viro.2000.0534 11021990
40. Nishizawa M Myojin T Nishino Y Nakai Y Kamata M Aida Y A carboxy-terminally truncated form of the Vpr protein of human immunodeficiency virus type 1 retards cell proliferation independently of G(2) arrest of the cell cycle Virology 1999, 263(2):313-322. 10.1006/ viro.1999.9905 10544105
41. Nishino Y Myojin T Kamata M Aida Y Human immunodeficiency virus type 1 Vpr gene product prevents cell proliferation on mouse NIH3T3 cells without the G2 arrest of the cell cycle Biochem Biophys Res Commun 1997, 232(2):550-554. 10.1006/bbrc.1997.6186 9125220
42. Cormack BP Valdivia RH Falkow S FACS-optimized mutants of the green fluorescent protein (GFP) Gene 1996, 173(1 Spec No):33-38. 10.1016/ 0378-1119(95)00685-0 8707053
43. Gey GO Coffman WD Kubicek MT Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium Cancer Res 1952, 12(4):264-265.
44. Goldstein MN Slotnick IJ Journey LJ In vitro studies with HeLa cell line sensitive and resistant to actinomycin D Ann N Y Acad Sci 1960, 89:474-483. 10.1111/j.1749-6632.1960.tb20171.x 13706673
45. DuBridge RB Tang P Hsia HC Leong PM Miller JH Calos MP Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system Mol Cell Biol 1987, 7(1):379-387. 365079 3031469
46. Aden DP Fogel A Plotkin S Damjanov I Knowles BB Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line Nature 1979, 282(5739):615-616. 10.1038/282615a0 233137
47. Knowles BB Howe CC Aden DP Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen Science 1980, 209(4455):497-499. 10.1126/science.6248960 6248960
48. R-Development-Core-Team R: A language and environment for statistical computing Vienna, Austria: R Foundation for Statistical Computing 2.8 2008.